Subscribe to RSS
Download PDF
DOI: 10.1055/s-0038-1628514
Kognitive Remediation
Rehabilitation von Menschen mit Erkrankungen aus dem schizophrenen FormenkreisCognitive remediaton improves response to psychiatric rehabilitation in persons with schizophrenic spectrum disordersPublication History
eingegangen am:
10 January 2013
angenommen am:
09 February 2013
Publication Date:
24 January 2018 (online)
Zusammenfassung
Rehabilitation von Menschen mit schizophrenen Psychosen zielt auf die Erhaltung und/oder die Verbesserung komplexer Alltagsfunktionen wie Wohnen, Arbeit und Sozialbeziehungen ab. Kognitive Funktionen, die bei der überwiegenden Mehrheit der Erkrankten erheblich beeinträchtigt sind, haben sich als die besten Prädiktoren für die Alltagsfunktionalität erwiesen. Die Behandlung kognitiver Defizite bietet daher einen rationalen Ansatz für Interventionen im Rahmen der psychiatrischen Rehabilitation. Der vorliegende Beitrag fasst die aktuelle Evidenz zur Behandlung kognitiver Störungen bei Schizophrenien zusammen und bewertet ihre Bedeutung für die Erreichung psychiatrischer Rehabilitationsziele. Die Behandlung kognitiver Defizite bei an Schizophrenie erkrankten Menschen ist möglich und im Sinne der zentralen Rehabilitationsziele erfolgreich. Kognitive Remediation sollte einen zentralen Platz in der psychiatrischen Rehabilitation einnehmen.
Summary
Psychiatric rehabilitation for persons with schizophrenia aims at preservation and improvement of psychosocial functions in areas such as work, social relationship and independent living. Cognitive functioning is impaired in schizophrenic patients and was shown to be a robust predictor of psychosocial functioning. This qualifies cognitive functioning as an appropriate and rational target for rehabilitative interventions. This article summarizes evidence concerning the therapy of cognitive deficits in schizophrenia and describes its impact on psychiatric rehabilitation. Cognitive remediation therapy produces moderate improvements in cognitive performance and, when combined with functional training and embedded in comprehensive psychiatric rehabilitation, also enhances functional outcomes. We conclude that therapy of cognitive functioning provides an important tool for psychiatric rehabilitation.
-
Literatur
- 1 Ramsay CE. et al. Life and treatment goals of individuals hospitalized for first-episode nonaffective psychosis. Psychiatry Res 2011; 189: 344-8.
- 2 Salize HJKR. Gesundheitsökonomie in der Psychiatrie – Konzepte, Methoden, Analysen. Stuttgart: Kohlhammer 2010
- 3 Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 1996; 321-30.
- 4 Keefe RS. et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 2006; 153: 2033-46.
- 5 Kraepelin E. Psychiatrie. Leipzig: Barth 1909
- 6 Bleuler E. Dementia Praecox oder die Gruppe der Schizophrenien. 1. Aufl. Leipzig: Deuticke 1911
- 7 Watson CG. et al. Differentiation of organics from schizophrenics at two chronicity levels by use of the Reitan-Halstead Organic Test Battery. Journal of Consulting and Clinical Psychology 1968; 32: 679-84.
- 8 Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12: 426-45.
- 9 Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 2004; 72: 21-8.
- 10 Hughes C. et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res 2003; 59: 137-46.
- 11 Nuechterlein KH, Dawson ME. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 1984; 10: 160-203.
- 12 Nuechterlein KH. Childhood precursors of adult schizophrenia. J Child Psychol Psychiatry 1986; 133-44.
- 13 Cornblatt BA. et al. Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia. Br J Psychiatry 1992; Suppl. 27: 59-64.
- 14 Bilder R. et al. Neuropsychological deficits in the early course of first episode schizophrenia. Schizophr Res 1991; 198-9.
- 15 Heaton RK. et al. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001; 05: 24-32.
- 16 Pfüller U. et al. Behandlung kognitiver Defizite bei Schizophrenie. Teil I: Diagnostik und psychologische Verfahren. Nervenarzt 2010; 81: 556-63.
- 17 Roesch-Ely D. et al. Behandlung kognitiver Defizite bei Schizophrenie. Teil II: Pharmakologische Strategien. Nervenarzt 2010; 81: 564-76.
- 18 Bowie CR. et al. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional ompetence, and real-world behavior. Am J Psychiatry 2012; 769: 710-8.
- 19 Mishara AL, Goldberg TE. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol Psychiatry 2004; 55: 1013-22.
- 20 Medalia A, Gold J, Merriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics. Arch Clin Neuropsychol 1988; 03: 249-71.
- 21 Purdon SE. et al. Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology 2003; 169: 390-7.
- 22 Blyler C RGJM. Cognitive effects of typical antipsychotic treatment: another look. Sharma THP. (ed.). Oxford: Oxford University Press; 2000
- 23 Strauss ME, Reynolds KS, Jayaram G, Tune LE. Effects of anticholinergic medication on memory in schizophrenia. Schizophr Res 1990; 03: 127-9.
- 24 Woodward ND. et al. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizophr Res 2007; 89: 211-24.
- 25 Hagger C. et al. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993; 34: 702-12.
- 26 Zahn TP, Pickar D, Haier RJ. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophr Res 1994; 13: 133-44.
- 27 Potkin SG, Fleming K, Jin Y, Gulasekaram B. Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics. J Clin Psychopharmacol 2001; 21: 479-83.
- 28 Weickert TW. et al. Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Neuropsychopharmacology 2003; 28: 1491-500.
- 29 Keefe RS. et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 2007; 64: 633-47.
- 30 Barnett JH. et al. Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling. BMC Psychiatry 2007; 07: 16.
- 31 Goldberg TE. et al. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?. Arch Gen Psychiatry 2007; 64: 1115-22.
- 32 Roesch-Ely D. et al. Differential dopaminergic modulation of executive control in healthy subjects. Psychopharmacology 2005; 178: 420-30.
- 33 Roesch-Ely D. et al. Dopaminergic modulation of semantic priming in healthy volunteers. Biol Psychiatry 2006; 60: 604-11.
- 34 Wykes T. et al. Schizophrenia: methodology and effect sizes. Am J Psychiatry 2011; 168: 472-85.
- 35 Dickinson D. et al. A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia. Am J Psychiatry 2010; 167: 170-180.
- 36 Goldberg T. et al. Further evidence for dementia of the prefrontal type in schizophrenia. A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 1987; 44: 1008-14.
- 37 Suslow T, Schonauer K, Arolt V. Attention training in the cognitive rehabilitation of schizophrenic patients: a review of efficacy studies. Acta Psychiatr Scand 2001; 103: 15-23.
- 38 Rodewald K. et al. Planning and problem-solving training for patients with schizophrenia: a randomized controlled trial. BMC Psychiatry 2011; 11: 73.
- 39 Olbrich R. Psychologische Verfahren zur Reduktion kognitiver Defizite. Fortschr Neurol Psychiatr 1999; 67: 74-6.
- 40 Sartory G. et al. Computerized cognitive remediation improves verbal learning and processing speed in schizophrenia. Schizophr Res 2005; 75: 219-23.
- 41 Wexler BE. et al. Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises. Am J Psychiatry 2000; 15: 1694-7.
- 42 Bor J. et al. How can cognitive remediation therapy modulate brain activations in schizophrenia? An fMRI study. Psychiatry Res 2011; 192: 160-6.
- 43 McGurk SR, Mueser KT, Pascaris A. Cognitive training and supported employment for persons with severe mental illness: one-year results from a randomized controlled trial. Schizophr Bull 2005; 31: 898-909.
- 44 McGurk SR. et al. Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial. Am J Psychiatry 2007; 164: 437-41.
- 45 Vauth R. et al. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation. Schizophr Bull 2005; 31: 55-66.
- 46 McGurk SR. et al. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry 2007; 164: 1791-802.
- 47 Reeder C, Newton E, Frangou S, Wykes T. Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophr Bull 2004; 30: 87-100.
- 48 Müller DR, Roder V, Brenner HD. Effektivität des Integrierten Psychologischen Therapieprogramms für schizophren Erkrankte. Nervenarzt 2007; 78: 62-73.
- 49 Roder V, Mueller DR, Schmidt SJ. Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update. Schizophr Bull 2011; 37 (Suppl. 02) 71-9.
- 50 Salize HJ. Die Psychiatrische Rehabilitation wird zu einem der Zukunftsthemen der Psychiatrie – Pro & Kontra. Psychiatr Prax 2012; 39: 317-8.
- 51 Watzke et al. Dynamisch kognitives Testen in der Auswahl optimaler rehabilitativer Versorgungsangebote. Nervenheilkunde 2013; 32: 363-369.